WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
Las nuevas jeringas "inteligentes" que la OMS recomienda para la administración de inyecciones por vía intramuscular, intradérmica y subcutánea tienen características que impiden su reutilización. Algunos modelos tienen un punto débil en el émbolo que provoca su rotura, si el usuario intenta tirar h...
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| التنسيق: | Monograph |
| اللغة: | الإنجليزية |
| منشور في: |
Ginebra
World Health Organization
2015
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | Enlace web Path |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة: WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
- Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
- Heating injection drug preparation equipment used for opioid injection may reduce HIV transmission associated with sharing equipment
- Evidence for the effectiveness of interventions to prevent infections: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour among people who inject drugs
- Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
- Needle & Syringe Programs in prisions. An international review
- Prevention and control of infectious diseases among people who inject drugs